146 related articles for article (PubMed ID: 16596270)
41. [Potential of chondrogenesis of bone marrow stromal cells co-cultured with chondrocytes on biodegradable scaffold: in vivo experiment with pigs and mice].
Liu X; Zhou GD; Lü XJ; Liu TY; Zhang WJ; Liu W; Cao YL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1929-33. PubMed ID: 17923021
[TBL] [Abstract][Full Text] [Related]
42. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
43. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
44. Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.
Xu C; Graf LF; Fazli L; Coleman IM; Mauldin DE; Li D; Nelson PS; Gleave M; Plymate SR; Cox ME; Torok-Storb BJ; Knudsen BS
Prostate; 2007 Nov; 67(15):1621-9. PubMed ID: 17823924
[TBL] [Abstract][Full Text] [Related]
45. NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone.
Andela VB; Gordon AH; Zotalis G; Rosier RN; Goater JJ; Lewis GD; Schwarz EM; Puzas JE; O'Keefe RJ
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S75-85. PubMed ID: 14600595
[TBL] [Abstract][Full Text] [Related]
46. Gene expression in cancer cells is influenced by contact with bone cells in a novel coculture system that models bone metastasis.
Satcher RL; Dvorkin K; Levenson AS; Vandenbroek T; Stupp SI
Clin Orthop Relat Res; 2004 Sep; (426):54-63. PubMed ID: 15346052
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format.
Lessard J; Aicha SB; Fournier A; Calvo E; Lavergne E; Pelletier M; Labrie C
Prostate; 2007 Jun; 67(8):808-19. PubMed ID: 17373718
[TBL] [Abstract][Full Text] [Related]
48. Maspin reduces prostate cancer metastasis to bone.
Hall DC; Johnson-Pais TL; Grubbs B; Bernal R; Leach RJ; Padalecki SS
Urol Oncol; 2008; 26(6):652-8. PubMed ID: 18367129
[TBL] [Abstract][Full Text] [Related]
49. Prostate cancer cell survival pathways activated by bone metastasis microenvironment.
Tenta R; Sotiriou E; Pitulis N; Thyphronitis G; Koutsilieris M
J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):135-44. PubMed ID: 15951629
[TBL] [Abstract][Full Text] [Related]
50. A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells.
Kawada M; Yoshimoto Y; Minamiguchi K; Kumagai H; Someno T; Masuda T; Ishizuka M; Ikeda D
Anticancer Res; 2004; 24(3a):1561-8. PubMed ID: 15274323
[TBL] [Abstract][Full Text] [Related]
51. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
52. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications.
Chung LW
Cancer; 2003 Feb; 97(3 Suppl):772-8. PubMed ID: 12548574
[TBL] [Abstract][Full Text] [Related]
53. Dynamic process of prostate cancer metastasis to bone.
Tantivejkul K; Kalikin LM; Pienta KJ
J Cell Biochem; 2004 Mar; 91(4):706-17. PubMed ID: 14991762
[TBL] [Abstract][Full Text] [Related]
54. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.
Yu YP; Landsittel D; Jing L; Nelson J; Ren B; Liu L; McDonald C; Thomas R; Dhir R; Finkelstein S; Michalopoulos G; Becich M; Luo JH
J Clin Oncol; 2004 Jul; 22(14):2790-9. PubMed ID: 15254046
[TBL] [Abstract][Full Text] [Related]
55. Early passage bone marrow stromal cells express genes involved in nervous system development supporting their relevance for neural repair.
Nandoe Tewarie RD; Bossers K; Ritfeld GJ; Blits B; Grotenhuis JA; Verhaagen J; Oudega M
Restor Neurol Neurosci; 2011; 29(3):187-201. PubMed ID: 21586825
[TBL] [Abstract][Full Text] [Related]
56. Bystin in perineural invasion of prostate cancer.
Ayala GE; Dai H; Li R; Ittmann M; Thompson TC; Rowley D; Wheeler TM
Prostate; 2006 Feb; 66(3):266-72. PubMed ID: 16245277
[TBL] [Abstract][Full Text] [Related]
57. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.
Sung SY; Chung LW
Differentiation; 2002 Dec; 70(9-10):506-21. PubMed ID: 12492493
[TBL] [Abstract][Full Text] [Related]
58. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
[TBL] [Abstract][Full Text] [Related]
59. Acute activation of gp130 gene expression in bone marrow stromal cells by contact with myeloma-derived lymphoblastic cell line ARH77 cell membranes.
Juneja HS; Lee S; Thomazy V; Shipley G; Davies PJ
J Interferon Cytokine Res; 2001 Mar; 21(3):157-66. PubMed ID: 11331038
[TBL] [Abstract][Full Text] [Related]
60. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
